Conclusion
This study reports demographic features of the consecutive 47 patients
treated at a new proton therapy centre in the initial 14 months. This
study also showed that PBT can bedelivered safely with acceptable acute
toxicitiesfor judiciously selected children and young adults with CNS
and non-CNS tumors. A longer follow-up is needed to evaluate its
efficacy with respect to disease outcomes and late toxicities.
Conflicts of interest: No